Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,481,054,510
-$349,931,557 QoQ
Shares Held
61,505,586
-16.4% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#8
of 2,816 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORGES BANK holds $48,449,655,630 across 13 Drug Manufacturers - General names. PFE ranks #9 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,471,413 | $13,759,158,041 | |
| 2 | JNJ |
Johnson & Johnson
|
31,825,084 | $8,082,616,583 | |
| 3 | ABBV |
AbbVie Inc.
|
25,554,538 | $6,430,543,942 | |
| 4 | AZN |
Astrazeneca PLC
|
33,864,172 | $6,421,324,294 | |
| 5 | MRK |
Merck & Co., Inc.
|
36,983,784 | $4,752,416,244 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
21,965,555 | $2,775,128,218 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
36,866,658 | $2,124,256,833 | |
| 8 | AMGN |
Amgen Inc
|
5,625,584 | $2,037,136,478 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,481,054,510 | 61,505,586 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $1,830,986,067 | 73,533,577 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $2,270,156,913 | 93,653,338 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,180,603,342 | 86,053,802 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $2,328,985,979 | 87,786,882 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,556,976,654 | 88,354,411 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $2,349,290,000 | 83,963,188 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,128,939,984 | 76,718,558 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $2,129,926,809 | 73,981,480 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,273,657,153 | 68,545,588 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $2,446,243,743 | 66,691,487 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $2,638,208,294 | 64,661,968 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $3,150,472,031 | 61,484,622 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,530,384,410 | 57,824,141 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $2,965,065,453 | 56,552,841 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $2,927,634,139 | 56,550,785 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $3,351,890,816 | 56,763,604 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $2,432,766,458 | 56,562,810 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $2,306,046,443 | 58,887,805 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $2,232,831,024 | 61,629,341 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $2,219,532,275 | 60,296,992 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $2,135,373,704 | 58,184,627 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $1,917,840,011 | 58,649,481 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $1,937,924,784 | 59,372,776 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||